Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization

Journal of Hematology and Oncology

Volumn 5, Issue , 2012, Pages

  Wang, Wen Quan ^a,b   Liu, Liang ^b   Sun, Hui Chuan ^a   Fu, Yan Ling ^c   Xu, Hua Xiang ^b   Chai, Zong Tao ^a   Zhang, Qiang Bo ^a   Kong, Ling Qun ^a   Zhu, Xiao Dong ^a   Lu, Lu ^a   Ren, Zheng Gang ^a   Tang, Zhao You ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c TONGJI UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Metastasis; Palliative resection; Tanshinone IIA; Vascular normalization

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TANSHINONE IIA; VASCULOTROPIN RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; IN VITRO STUDY; LIVER CELL CARCINOMA; METASTASIS; MOUSE; NONHUMAN; PALLIATIVE THERAPY; RECEPTOR DOWN REGULATION; TUMOR CELL; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, HEPATOCELLULAR; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DITERPENES, ABIETANE; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM METASTASIS; RANDOM ALLOCATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84868463251     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-5-69     Document Type: Article

References (31)

1. Hepatocellular carcinoma. El-Serag HB, N Engl J Med 2011 365 1118 1127 10.1056/NEJMra1001683 21992124
2. Hepatic resection but not radiofrequency ablation results in tumor growth and increased growth factor expression. Meredith K, Haemmerich D, Qi C, Mahvi D, Ann Surg 2007 245 771 776 10.1097/01.sla.0000261319.51744.59 17457170
3. Operative injury accelerates tumor growth by inducing mobilization and recruitment of bone marrow-derived stem cells. Takemoto Y, Li TS, Kubo M, Ohshima M, Ueda K, Harada E, Enoki T, Okamoto M, Mizukami Y, Murata T, Hamano K, Surgery 2011 149 792 800 10.1016/j.surg.2011.02.005 21507448
4. High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential. Wang L, Tang ZY, Qin LX, Wu XF, Sun HC, Xue Q, Ye SL, Hepatology 2000 32 43 48 10869287
5. Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model. Feng YX, Wang T, Deng YZ, Yang P, Li JJ, Guan DX, Yao F, Zhu YQ, Qin Y, Wang H, et al. Hepatology 2011 53 483 492 10.1002/hep.24075 21274870
6. Long-term interferon-alpha treatment suppresses tumor growth but promotes metastasis capacity in hepatocellular carcinoma. Zhuang PY, Zhang JB, Zhang W, Zhu XD, Liang Y, Xu HX, Xiong YQ, Kong LQ, Wang L, Wu WZ, et al. J Cancer Res Clin Oncol 2010 136 1891 1900 10.1007/s00432-010-0848-1 20213095
7. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Ebos JM, Lee CR, Cruz-Munoz W, Bjarnason GA, Christensen JG, Kerbel RS, Cancer Cell 2009 15 232 239 10.1016/j.ccr.2009.01.021 19249681
8. Surgical injury enhances the expression of genes that mediate breast cancer metastasis to the lung. Al-Sahaf O, Wang JH, Browne TJ, Cotter TG, Redmond HP, Ann Surg 2010 252 1037 1043 10.1097/SLA.0b013e3181efc635 21107114
9. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Rolny C, Mazzone M, Tugues S, Laoui D, Johansson I, Coulon C, Squadrito ML, Segura I, Li X, Knevels E, et al. Cancer Cell 2011 19 31 44 10.1016/j.ccr.2010.11.009 21215706
10. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Jain RK, Science 2005 307 58 62 10.1126/science.1104819 15637262
11. Normalization of the vasculature for treatment of cancer and other diseases. Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, Jain RK, Physiol Rev 2011 91 1071 1121 10.1152/physrev.00038.2010 21742796
12. Pericytes and vessel maturation during tumor angiogenesis and metastasis. Raza A, Franklin MJ, Dudek AZ, Am J Hematol 2010 85 593 598 10.1002/ajh.21745 20540157
13. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Mazzone M, Dettori D, Leite De Oliveira R, Loges S, Schmidt T, Jonckx B, Tian YM, Lanahan AA, Pollard P, Ruiz De Almodovar C, et al. Cell 2009 136 839 851 10.1016/j.cell.2009.01.020 19217150
14. Surgery and angiogenesis. van der Bilt JD, Borel Rinkes IH, Biochim Biophys Acta 2004 1654 95 104 14984770
15. Transplanting normal vascular proangiogenic cells to tumor-bearing mice triggers vascular remodeling and reduces hypoxia in tumors. Sasajima J, Mizukami Y, Sugiyama Y, Nakamura K, Kawamoto T, Koizumi K, Fujii R, Motomura W, Sato K, Suzuki Y, et al. Cancer Res 2010 70 6283 6292 10.1158/0008-5472.CAN-10-0412 20631070
16. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen PJ, Zhu M, et al. Cancer Cell 2007 11 83 95 10.1016/j.ccr.2006.11.021 17222792
17. Herbal compound "Songyou Yin" reinforced the ability of interferon-alfa to inhibit the enhanced metastatic potential induced by palliative resection of hepatocellular carcinoma in nude mice. Huang XY, Huang ZL, Wang L, Xu YH, Ai KX, Zheng Q, Tang ZY, BMC Cancer 2010 10 580 10.1186/1471-2407-10-580 20969807
18. Herbal extract "Songyou Yin" inhibits tumor growth and prolongs survival in nude mice bearing human hepatocellular carcinoma xenograft with high metastatic potential. Huang XY, Wang L, Huang ZL, Zheng Q, Li QS, Tang ZY, J Cancer Res Clin Oncol 2009 135 1245 1255 10.1007/s00432-009-0566-8 19277711
19. Tanshinone IIA modulates pulmonary vascular response to agonist and hypoxia primarily via inhibiting Ca2+ influx and release in normal and hypoxic pulmonary hypertension rats. Wang J, Dong MQ, Liu ML, Xu DQ, Luo Y, Zhang B, Liu LL, Xu M, Zhao PT, Gao YQ, Li ZC, Eur J Pharmacol 2010 640 129 138 10.1016/j.ejphar.2010.04.047 20460121
20. Direct vasorelaxation by a novel phytoestrogen tanshinone IIA is mediated by nongenomic action of estrogen receptor through endothelial nitric oxide synthase activation and calcium mobilization. Fan G, Zhu Y, Guo H, Wang X, Wang H, Gao X, J Cardiovasc Pharmacol 2011 57 340 347 10.1097/FJC.0b013e31820a0da1 21383591
21. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Wang L, Zhou GB, Liu P, Song JH, Liang Y, Yan XJ, Xu F, Wang BS, Mao JH, Shen ZX, et al. Proc Natl Acad Sci U S A 2008 105 4826 4831 10.1073/pnas.0712365105 18344322
22. Experimental studies of factors influencing hepatic metastases, III. Effect of surgical trauma with special reference to liver injury. Fisher B, Fisher ER, Ann Surg 1959 150 731 744 10.1097/00000658-195910000-00015 13823186
23. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D, J Clin Invest 2003 111 1287 1295 12727920
24. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms. Erber R, Thurnher A, Katsen AD, Groth G, Kerger H, Hammes HP, Menger MD, Ullrich A, Vajkoczy P, FASEB J 2004 18 338 340 14657001
25. Hepatocellular carcinoma: insight from animal models. Li Y, Tang ZY, Hou JX, Nat Rev Gastroenterol Hepatol 2011 9 32 43 10.1038/nrgastro.2011.196 22025031
26. Biological characteristics of fluorescent protein-expressing human hepatocellular carcinoma xenograft model in nude mice. Yang BW, Liang Y, Xia JL, Sun HC, Wang L, Zhang JB, Tang ZY, Liu KD, Chen J, Xue Q, et al. Eur J Gastroenterol Hepatol 2008 20 1077 1084 10.1097/MEG.0b013e3283050a67 19047839
27. Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells. Xiong YQ, Sun HC, Zhang W, Zhu XD, Zhuang PY, Zhang JB, Wang L, Wu WZ, Qin LX, Tang ZY, Clin Cancer Res 2009 15 4838 4846 10.1158/1078-0432.CCR-08-2780 19638466
28. Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues. Sun FX, Tang ZY, Lui KD, Ye SL, Xue Q, Gao DM, Ma ZC, Int J Cancer 1996 66 239 243 10.1002/(SICI)1097-0215(19960410)66:2<239::AID-IJC17>3.0.CO;2-7 8603818
29. Efficacy of intra-hepatectomy 5-FU on recurrence and metastasis of human hepatocellular carcinoma in nude mice. Rashidi B, An Z, Sun FX, Li X, Tang ZY, Moossa AR, Hoffman RM, Int J Cancer 2001 91 231 235 10.1002/1097-0215(200002) 9999:9999<::AID-IJC1042>3.3.CO;2-O 11146450
30. A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice. Jia JB, Wang WQ, Sun HC, Liu L, Zhu XD, Kong LQ, Chai ZT, Zhang W, Zhang JB, Xu HX, et al. Invest New Drugs 2011 29 861 872 10.1007/s10637-010-9435-1 20414698
31. High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resection. Jia JB, Wang WQ, Sun HC, Zhu XD, Liu L, Zhuang PY, Zhang JB, Zhang W, Xu HX, Kong LQ, et al. Oncologist 2010 15 732 743 10.1634/theoncologist.2009-0170 20551429